Halozyme Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals, Inc. |
$33.54 | $2.70 B | -7.55 | 486 | $36.50 M |
ALEC
Alector, Inc. |
$2.02 | $420.24 M | -3.14 | 238 | $100.56 M |
ALNY
Alnylam Pharmaceuticals, Inc. |
$233.15 | $19.33 B | -57.65 | 2230 | $2.25 B |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BMRN
BioMarin Pharmaceutical Inc. |
$67.07 | $15.32 B | 76.12 | 3040 | $2.85 B |
BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CYTK
Cytokinetics, Incorporated |
$49.19 | $6.05 B | -9.78 | 498 | $18.47 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
EXEL
Exelixis, Inc. |
$33.20 | $6.37 B | 33.66 | 1147 | $2.17 B |
INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
INSM
Insmed Incorporated |
$66.62 | $9.17 B | -10.87 | 1271 | $363.71 M |
LEGN
Legend Biotech Corporation |
$34.72 | $8.31 B | -17.66 | 2500 | $627.24 M |
LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$42.66 | $3.44 B | -5.21 | 1294 | $560.23 M |
SGEN
Seagen Inc. |
$228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
VRDN
Viridian Therapeutics, Inc. |
$20.07 | $776.72 M | -2.71 | 143 | $302,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
